— Know what they know.
Not Investment Advice
Also trades as: ENSCW (OTC) · $vol 0M

ENSC NASDAQ

Ensysce Biosciences, Inc.
1W: -9.8% 1M: +12.2% 3M: +78.0% YTD: -52.1% 1Y: -79.8% 3Y: -97.6% 5Y: -100.0%
$0.45
-0.00 (-0.02%)
 
Weekly Expected Move ±13.5%
$0 $0 $0 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 50 · $8.8M mcap · 19M float · 62.17% daily turnover · Short 17% of daily vol
Credit Risk of going bust: higher than 81% of companies Debt: 2.2% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.00 (down 99%), Ensysce Biosciences, Inc. would be worth roughly what it owes.
Total debt $197K against a stock market value of $8.8M.
Distance to default 2.50 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $197K (short-term plus half of long-term), stock volatility 126.4%; Altman Z'' -192.37. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

ETF Exposure

2
ETFs Holding
Total ETF Value
0.00%
Max Weight
0.000%
Avg Weight

ETF Holdings by Value

ETFs Holding ENSC

# ETF Weight Value Holdings Top 10 Wt P/E Div Yield Sector Mix
1 FSMAX
—% 3,181 8.8% 12.6 0.01%
2 VXF
Vanguard Extended Market ETF
0.0000% 3,322 9.5% 3.8 0.01%
3 VEMPX
0.0000% 3,322 9.5% 3.8 0.01%
4 VEXAX
0.0000% 3,322 9.5% 3.8 0.01%
5 VIEIX
0.0000% 3,322 9.5% 3.8 0.01%
Tech Financial Healthcare Consumer Cycl. Industrials Energy

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms